Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies

Neurodegenerative diseases are currently among the most devastating diseases with no effective disease-modifying drugs in the market, with Alzheimer’s disease (AD) being the most prevalent. AD is a complex multifactorial neurodegenerative disorder characterized by progressive and severe cognitive im...

Full description

Saved in:

Bibliographic Details
Main Authors:	Androulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomolecules
Subjects:	adrenergic receptors Alzheimer’s disease neurodegeneration neuroinflammation tauopathies beta amyloid
Online Access:	https://www.mdpi.com/2218-273X/15/1/128
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflammation
by: Chaokai Yang, et al.
Published: (2025-01-01)

Beta-adrenergic blocking agents in cutaneous and oral melanoma
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

Scrutinizing the evidence of anthracene toxicity on adrenergic receptor beta-2 and its bioremediation by fungal manganese peroxidase via in silico approaches
by: Muhammad Naveed, et al.
Published: (2025-01-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01)

Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms
by: Maria João da Costa Caiado, et al.
Published: (2025-02-01)

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool
by: Shigeo Sakuragi, et al.
Published: (2024-12-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
by: Jee Soo Park, et al.
Published: (2025-01-01)

Effect of Nebulisation with Dexmedetomidine versus Magnesium Sulphate on Haemodynamic Response to Laryngoscopy and Intubation and Incidence of Postoperative Sore Throat: A Randomised Clinical Trial
by: Fateh Pal Singh Gill, et al.
Published: (2025-01-01)

The Science of Memory Loss: Insights into Alzheimer’s Disease
by: Agnieszka Starzyk, et al.
Published: (2025-02-01)

Blood-based biomarkers and plasma Aβ assays in the differential diagnosis of Alzheimer’s disease and behavioral-variant frontotemporal dementia
by: Pablo Mohaupt, et al.
Published: (2024-12-01)

SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease
by: Mridula Bhalla, et al.
Published: (2025-01-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
by: Simona Denaro, et al.
Published: (2025-02-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
by: Masahiro Hata, et al.
Published: (2025-01-01)

The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
by: Sabine Werner, et al.
Published: (2020-06-01)

Isoforsythiaside confers neuroprotection against Alzheimer’s disease by attenuating ferroptosis and neuroinflammation in vivo and in vitro
by: Chunyue Wang, et al.
Published: (2023-09-01)

Human Endogenous Retroviruses and Their Putative Role in Pathogenesis of Alzheimer’s Disease, Inflammation, and Senescence
by: Patrycja Kozubek, et al.
Published: (2024-12-01)

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01)

The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease
by: Xueyan Liu, et al.
Published: (2025-11-01)

Insufficient Sleep and Alzheimer’s Disease: Potential Approach for Therapeutic Treatment Methods
by: Dieu Quynh Trinh, et al.
Published: (2024-12-01)

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China
by: Ziyu Liu, et al.
Published: (2025-01-01)

Mutations in human prion-like domains: pathogenic but not always amyloidogenic
by: Andrea Bartolomé-Nafría, et al.
Published: (2024-12-01)

Editorial: 15 years of Frontiers in Cellular Neuroscience: the dual role of microglia in (neuro)inflammation
by: Antonio J. Herrera, et al.
Published: (2025-02-01)

Inflammasomes in neurodegenerative diseases
by: Qianchen Wang, et al.
Published: (2024-12-01)

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression
by: Daniele Lana, et al.
Published: (2025-01-01)

Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
by: Vasil Kecheliev, et al.
Published: (2022-09-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

Alzheimer's disease and gut-brain axis: Drosophila melanogaster as a model
by: Samuel de Mattos Alves, et al.
Published: (2025-02-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic review
by: Aidan D. Tyrrell, et al.
Published: (2025-02-01)

The neurotoxicity of iodoacetic acid, a byproduct of drinking water disinfection
by: Xu Wang, et al.
Published: (2025-01-01)

Repeated low-intensity noise exposure exacerbates age-related hearing loss via RAGE signaling pathway
by: Jianbin Sun, et al.
Published: (2025-01-01)